Based on the characteristics of the CRISPR-Cas system that specifically cuts the target fragment, Wang et al. [71] combined CRISPR-Cas9 with traditional PCR to achieve the detection of the most common deletion mutation in exon 19 of EGFR in NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.